Drug Price

Healthcare analysts project a 50% increase in annual sales for weight-loss drugs, estimating a market value of $150 billion by the early 2030s. Key players include Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, which have captured widespread interest despite limited insurance coverage. Analysts note these drugs could soon be covered by insurers due to their potential in preventing costly health emergencies. Despite 2023 shortages, increased production is underway. Shares in Lilly and Novo have surged, reflecting their growing market dominance. Discover the future of obesity treatment with 80 experimental drugs in the pipeline.

National drug pricing body fixes ceiling prices of 51 drugs and 2 formulations

The price of 24 anti-diabetic formulations that lead with dapagliflozin and another 14 with vildagliptin and two with sitagliptin molecules were set

NLEM 2022 | Govt releases new list of 384 essential medicines; 34 drugs added, 26 dropped

Drugs used to treat diseases that are a public health problem in India, are comparatively cost effective and aligned with the current treatment guidelines are included in the National List of Essential Medicines

In Depth | Spadework begins for affordable medicines in India

As concerns grow about the rising unaffordability of drugs in India despite the country’s growing prowess as a pharma manufacturer, the government is looking to rework the way prices of medicines are determined

Economic Survey 2022| Govt initiative led to up to 89% fall in prices of key Covid devices

The prices of drugs and medical devices in India have long been under the scanner for unaffordability to a large chunk of the population but the government now claims that it is trying to fix a trade margin ceiling for many drugs, including the ones used in COVID treatment, to make them easily accessible to people.

50% costlier now: NPPA approves price rise for Carbamazepine, Ranitidine, Ibuprofen

The drug price regulation authority said that the "one-time price increase" of 50 percent is an "exceptional measure."

Affordable healthcare: Govt to review existing drug price control measures

The government plans to review the existing drug price control measures to make medicines more affordable, while also undertaking "re-engineering" of price regulator NPPA to bring greater transparency amid allegations from the industry over arbitrary implementation of policy.

NPPA fixes, revises prices of 18 essential drugs

Drug price regulator NPPA has capped the prices of four essential drugs and revised 14 more, including the ones used for treatment of fungal infections and hypertension.

79 demand notices issued to drug cos for overcharging: Govt

National drug price regulator NPPA has issued 79 demand notices to pharmaceutical companies for overcharging for non-scheduled medicines, Parliament was informed today.

NPPA approves norms for discontinuation of scheduled drugs

To ensure availability of essential drugs in the market, the drug pricing regulator NPPA is putting in place a framework for alternative arrangements in case of discontinuation of scheduled formulations by private pharma firms, among other measures.

NPPA sets ceiling price of 123 drugs in July

Drug price regulator NPPA fixed ceiling for 123 medicines last month while 118 cases of overcharging by pharmaceutical companies were detected during the period.

Pharma body challenges drug pricing policy in SC

Drug price controls based on market based rate, which was cleared by the cabinet is challenged in the Supreme Court through a public interest litigation filed by All India Drug Action Network (AIDAN), reports CNBC-TV18‘s Rituparna Bhuyan.